Abstract: The present invention relates to compositions and methods useful for the treatment of lupus using a humanized IgG1 anti-CD6 monoclonal antibody (T1h) that binds to the SRCR domain 1(D1) of CD6 without blocking the interaction of CD6 with the CD6 ligand Activated Leukocyte Cell Adhesion Molecule (ALCAM).
SOFT COPY ATTACHED IN PDF
| # | Name | Date |
|---|---|---|
| 1 | Sequence listing [21-10-2016(online)].txt | 2016-10-21 |
| 2 | Form3 _As Filed_21-10-2016.pdf | 2016-10-21 |
| 3 | Form2 Title Page_Complete_21-10-2016.pdf | 2016-10-21 |
| 4 | Drawing_As Filed_21-10-2016.pdf | 2016-10-21 |
| 5 | Description Complete_As Filed_21-10-2016.pdf | 2016-10-21 |
| 6 | Claims_As Filed_21-10-2016.pdf | 2016-10-21 |
| 7 | Abstract_As Filed_21-10-2016.pdf | 2016-10-21 |
| 8 | Form26_Power of Attorney_08-12-2016.pdf | 2016-12-08 |
| 9 | Correspondence by Agent_Pa_08-12-2016.pdf | 2016-12-08 |
| 10 | Correspondence by Agent_Pa_10-12-2016.pdf | 2016-12-10 |
| 11 | 201641036145-REQUEST FOR CERTIFIED COPY [26-10-2017(online)].pdf | 2017-10-26 |
| 12 | 201641036145-FORM 3 [31-10-2017(online)].pdf | 2017-10-31 |
| 13 | 201641036145-FORM 3 [21-05-2018(online)].pdf | 2018-05-21 |
| 14 | 201641036145-FORM 3 [22-11-2018(online)].pdf | 2018-11-22 |
| 15 | 201641036145-FORM 3 [20-05-2019(online)].pdf | 2019-05-20 |
| 16 | 201641036145-FORM 18 [14-09-2019(online)].pdf | 2019-09-14 |
| 17 | 201641036145-FORM 3 [21-11-2019(online)].pdf | 2019-11-21 |
| 18 | 201641036145-FORM 3 [21-05-2020(online)].pdf | 2020-05-21 |
| 19 | 201641036145-FORM 3 [16-11-2020(online)].pdf | 2020-11-16 |
| 20 | 201641036145-FORM 3 [15-05-2021(online)].pdf | 2021-05-15 |
| 21 | 201641036145-FORM 3 [19-11-2021(online)].pdf | 2021-11-19 |
| 22 | 201641036145-FER.pdf | 2022-03-16 |
| 23 | 201641036145-FORM 3 [19-05-2022(online)].pdf | 2022-05-19 |
| 24 | 201641036145-OTHERS [14-09-2022(online)].pdf | 2022-09-14 |
| 25 | 201641036145-FER_SER_REPLY [14-09-2022(online)].pdf | 2022-09-14 |
| 26 | 201641036145-CLAIMS [14-09-2022(online)].pdf | 2022-09-14 |
| 27 | 201641036145-ABSTRACT [14-09-2022(online)].pdf | 2022-09-14 |
| 28 | 201641036145-FORM 3 [16-11-2022(online)].pdf | 2022-11-16 |
| 29 | 201641036145-FORM 3 [16-05-2023(online)].pdf | 2023-05-16 |
| 30 | 201641036145-US(14)-HearingNotice-(HearingDate-04-12-2023).pdf | 2023-11-07 |
| 31 | 201641036145-FORM 3 [16-11-2023(online)].pdf | 2023-11-16 |
| 32 | 201641036145-Correspondence to notify the Controller [01-12-2023(online)].pdf | 2023-12-01 |
| 33 | 201641036145-Written submissions and relevant documents [11-12-2023(online)].pdf | 2023-12-11 |
| 34 | 201641036145-PatentCertificate28-12-2023.pdf | 2023-12-28 |
| 35 | 201641036145-IntimationOfGrant28-12-2023.pdf | 2023-12-28 |
| 1 | SEARCHSTRATEGYE_15-03-2022.pdf |